Cadrenal Therapeutics, Inc. CVKD 深 沪
已收盘 06-12 16:00:00 美东时间
3.70
-0.330
-8.19%
华盛通- 最 高4.24
- 今 开4.05
- 成交量 11.11万股
- 最 低 3.70
- 昨 收 4.03
- 总市值 1061.25万
- 52周最高 14.64
- 市盈率 静 --
- 换手率 3.87%
- 52周最低 3.70
- 委 比 -91.07%
- 总股本 286.82万
- 历史最高 101.25
- 量 比 1.51
- 振 幅 13.40%
- 历史最低 3.70
- 每 手 1
- 风险率 3.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cadrenal Therapeutics Announces Participation In BIO 2026; To Host Partnering Meetings To Discuss Development And Commercialization Opportunities For Differentiated Pipeline, Headlined By CAD-1005 And Tecarfarin
Lead asset CAD-1005 being researched for prevention of life-threatening blood clots in patients with Heparin-induced Thrombocytopenia (HIT), targets $2 billion peak annual revenue potential12-LOX could play a central
06-03 21:05
Cadrenal Therapeutics Q1 EPS $(1.04) Beats $(1.62) Estimate
Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(1.04) per share which beat the analyst consensus estimate of $(1.62) by 35.8 percent. This is a 50.24 percent increase over losses of $(2.09) per share
05-07 21:00
Cadrenal Therapeutics Receives FDA Guidance For Phase 3 Trial Of CAD-1005 Heparin-Induced Thrombocytopenia Treatment
Cadrenal has completed its End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) and receiving guidance on key elements of the Phase 3 pivotal trial for CAD-1005.The meeting with the FDA provided
04-30 20:37
美股大行评级 | 高盛首予PayPay“买入”评级；神经分泌生物科学获花旗等多家机构上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从13美元升至20美元；韦德布什：维持FuboTV"跑赢大市"评级，目标价从3.5美元升至24美元
04-08 18:35
Cadrenal Therapeutics shares are trading higher. The company reported Q4 financial results.
Cadrenal Therapeutics shares are trading higher. The company reported Q4 financ...
04-01 03:35
Cadrenal Therapeutics Q4 EPS $(1.41) Misses $(1.18) Estimate
Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(1.41) per share which missed the analyst consensus estimate of $(1.18) by 19.49 percent. This is a 49.64 percent increase over losses of $(2.80) per
03-31 22:15
美股夜盘 | 正业生物涨31.83%，Above Food Ingredients涨24.70%
正业生物涨31.83%；Above Food Ingredients涨24.70%；Faraday Future Intelligent Electric涨20.09%
03-23 10:02
美股夜盘 | 正业生物涨28.23%，Above Food Ingredients涨25.39%
正业生物涨28.23%；Above Food Ingredients涨25.39%；Faraday Future Intelligent Electric涨20.09%
03-23 09:02
美股夜盘 | Above Food Ingredients涨34.29%，正业生物涨27.14%
Linkhome Holdings Inc.涨-13.45%；Next Technology涨-13.00%；DRDGOLD Ltd. Sponsored ADR涨-11.06%
03-23 08:10
Cadrenal Therapeutics Highlights Recent Scientific Findings Demonstrating Potential Of 12-Lipoxygenase Inhibitor, CAD-1005, To Target Inflammatory Consequences Of Obesity And Type 2 Diabetes
Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing innovative treatments for life-threatening immune and thrombotic conditions, today highlighted recent scientific findings demonstrating
03-12 20:05
